Abstract:Objective To investigate the clinical relationship between transcription factor activator protein 2α (TFAP-2α) and transcription factor activator protein 2β (TFAP-2β) expression in colorectal cancer and recurrence after laparoscopic radical surgery.Methods 147 colorectal cancer patients who underwent laparoscopic radical resection were selected as the research objects. The expressions of TFAP-2α and TFAP-2β proteins were detected by immunohistochemical method. According to the recurrence of the patient 3 years after surgery, they were divided into the recurrence group and the non-recurrence group. Comparing the expression of TFAP-2α and TFAP-2β between cancer tissue and normal tissue at the cutting edge, as well as between the recurrence group and the non-recurrence group. The influencing factors of recurrence were analyzed by Cox regression analysis.Results The positive expression rates of TFAP-2α and TFAP-2β proteins in colorectal cancer tissue were lower than those in normal tissues at the cutting edge (P < 0.05). During the follow-up period, the postoperative recurrence rate of colorectal cancer patients was 23.13%. The positive expression rates of TFAP-2α and TFAP-2β proteins in recurrence patients were lower than those in non-recurrence patients (P < 0.05). The proportions of pathological stages T3 to T4, N1 to N2, vascular invasion stage in cancer tissues of recurrent patients were higher than those of non-recurrence patients (P < 0.05). Cox regression analysis showed that pathological stages T3 to T4, N1 to N2, vascular invasion and the decrease of cancer tissue TFAP-2α and TFAP-2β proteins positive expression rates were risk factors for recurrence after laparoscopic radical resection of colorectal cancer (P < 0.05).Conclusion The positive expression rates of TFAP-2α and TFAP-2β in cancer tissue of colorectal cancer patients are lower. The decrease of their positive expression rate, the high proportion of pathological stages T3 to T4, N1 to N2 and vascular invasion are risk factors for recurrence after laparoscopic radical resection of colorectal cancer.